Author: Trial Support

0

Early Site & Investigator Engagement In HR⁺/HER2⁻ Breast Cancer Trials: Foundations For Better Trial Design

Early site and investigator engagement are the foundations of effective clinical trial design, ensuring that protocols are both practical and patient-focused. This helps sponsors refine eligibility criteria, diagnostic pathways, and recruitment strategies for any planned trial. This is especially required in Hormone Receptor-Positive (HR⁺)/Human Epidermal Growth Factor Receptor 2-Negative (HER2⁻) metastatic breast cancer, where ever-evolving […]

Read More →
0

Partnering With Site Networks In Rare Disease Trials: Why Is It Important For Your Clinical Trials

Partnering with site networks offers a strategic solution to overcome the unique challenges of conducting clinical trials in rare diseases. Limited patient populations, complex recruitment pathways, and the geographic dispersion of expertise often hinder the progress of these trials. By leveraging established relationships, specialized knowledge, and streamlined processes, site networks can enhance trial efficiency, accelerate […]

Read More →
0

Modernizing Clinical Trials: The Role of eTMF, CTMS, and EDC Integration

The integration of Electronic Trial Master File (eTMF), Clinical Trial Management System (CTMS), and Electronic Data Capture (EDC) is transforming how clinical trials are planned, managed, and executed. By connecting these systems, organizations can eliminate data silos, reduce manual errors, and ensure real-time information flow across trial stakeholders. This integration enhances regulatory compliance, improves trial […]

Read More →
0

Mastering Clinical Operations In Asia-Pacific: Overcoming Challenges With Smart Solutions

Clinical operations in the Asia Pacific are rapidly evolving, driven by increasing regulatory harmonization, diverse patient populations across all therapeutic indications, and the adoption of innovative technologies such as decentralized clinical trial platforms, real-time data capture and analysis tools, and AI-powered site selection systems, making the region a strategic hub for current and upcoming global […]

Read More →
0

Why India Leads Global BA/BE Studies in 2025: Strategic Advantages for International Submissions

BA/BE studies 2025 are essential for global generic drug submissions. As the number of submissions continues to increase, countries are actively enhancing their capabilities to keep pace. India has positioned itself as a preferred destination, supported by its technical expertise, growing infrastructure, and regulatory alignment. BA/BE studies are cornerstones in developing and approving generic medicines, […]

Read More →
0

Beyond The Feasibility Questionnaire: Rethinking Feasibility Assessments In Asia-Pacific Trials

In clinical trials, traditional feasibility is often assessed through a feasibility questionnaire means figuring out if a planned study can run, whether it’s practically possible, ethically sound, and likely to work at the specific site or within the region where it’s proposed. Beyond the feasibility questionnaire, determining if a clinical trial will work is extremely […]

Read More →
0

DCGI Approval In India: A Complete Guide To Drug Regulations, Clinical Trials, & Patient Safety

The Drugs Controller General of India (DCGI) heads the Central Drugs Standard Control Organization (CDSCO), overseeing DCGI approval in India, regulation, and quality standards of drugs and clinical trials. As the national regulatory authority, DCGI ensures patient safety and compliance with the Drugs and Cosmetics Act, 1940. DCGI in the Indian pharmaceutical and medical device […]

Read More →
0

The Future Of Data: How AI In Electronic Data Capture (EDC) Is Transforming Clinical Trials

AI in Electronic Data Capture (EDC) in clinical trials is reshaping how research teams collect, manage, and interpret study data. At its core, EDC is a software system designed to replace paper case report forms (CRFs) by enabling structured, digital data collection for clinical research. It allows investigators and site staff to enter, verify, and […]

Read More →
0

A Guide To Essential Clinical Trial Tools & Systems For Smarter, Faster Studies

Essential clinical trial tools and systems, such as CTMS (Clinical Trial Management System), eTMF (electronic Trial Master File), eConsent, and eCOA (electronic Clinical Outcome Assessment), form the digital backbone of modern research operations. These platforms simplify study planning, documentation, patient engagement, and data collection. They ensure trials are more efficient, compliant, and focused on patients. […]

Read More →
0

BA/BE Study Requirements For FDA Approval: Guidelines, Global Locations, Costs & Quality Standards

For anyone seeking generic drug approval in the USA, a Bioavailability and Bioequivalence (BA/BE) study is often a critical step. These studies show the FDA that your product works just like the approved brand-name version, meeting strict guidelines for safety and effectiveness. Choosing the right global location for your trial, managing costs, and ensuring the […]

Read More →